Metabolic and Bariatric Surgery in Children: Current Practices and Outcomes

Shayan A Shah1, Noor A Khan2, Faisal G Qureshi3

  • 1Aga Khan University, Karachi, Pakistan.

Current Obesity Reports
|January 3, 2024
PubMed

Insights

Metabolic and Bariatric Surgery (MBS) offers safe and effective weight loss for children with obesity, improving related health issues. Laparoscopic sleeve gastrectomy is preferred, though few adolescents receive this treatment.

Area of Science:

  • Pediatric Endocrinology
  • Surgical Obesity Management
  • Adolescent Health

Background:

  • Childhood obesity is a growing epidemic with significant long-term health consequences.
  • Metabolic and Bariatric Surgery (MBS) is increasingly considered for severe pediatric obesity.
  • Current evidence on MBS in children requires synthesis to guide clinical practice.

Purpose of the Study:

  • To review current evidence on Metabolic and Bariatric Surgery (MBS) in pediatric patients.
  • To evaluate weight loss outcomes and improvement in comorbid conditions post-MBS.
  • To compare surgical versus non-surgical interventions and propose an evidence-based approach.

Main Methods:

  • Systematic review of current literature on pediatric MBS.
  • Analysis of weight loss data and comorbid condition resolution.
  • Comparison of MBS with pharmacologic and lifestyle interventions.

Main Results:

  • Metabolic and Bariatric Surgery (MBS) is a safe and effective option for carefully selected pediatric patients, yielding significant and lasting weight loss.
  • Laparoscopic sleeve gastrectomy (LSG) is the leading procedure due to its favorable safety profile.
  • Despite proven benefits, MBS is underutilized in adolescents; new pharmacologic agents show promise but lack long-term data.

Conclusions:

  • Metabolic and Bariatric Surgery (MBS) is a recommended and effective tool for managing pediatric obesity.
  • Early referral to multidisciplinary teams is crucial for identifying suitable candidates.
  • Further research is needed on long-term outcomes of both MBS and new pharmacologic therapies in children.
Abstract